| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $111,816,004 ) (Continued on the next page) |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA279550 | Mechanisms Promoting Copper Dependent Cell Death in Cancer | 002 | 3 | NIH | 6/30/2025 | $595,634 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK135541 | Autonomic control of kidney function | 000 | 3 | NIH | 5/13/2025 | $650,777 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AA030770 | Cholesterol toxicity in alcohol-associated hepatitis | 000 | 3 | NIH | 7/9/2025 | $681,678 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23MH127464 | The Impact of Insufficient Sleep and Insomnia Disorder on Behavioral and Neural Markers of Emotion Regulation | 000 | 4 | NIH | 6/10/2025 | $158,231 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL164976 | Pulmonary Vascular Pruning on Computed Tomography and Interstitial Lung Disease Outcomes | 000 | 3 | NIH | 3/12/2025 | $191,484 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK134427 | Feedforward Activation of AgRP Neurons and Hunger | 000 | 3 | NIH | 5/13/2025 | $509,395 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK140239 | Regulation and Requirements for Coenzyme A Biosynthesis | 000 | 1 | NIH | 8/5/2025 | $737,034 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R35CA294015 | Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint Immunotherapy | 000 | 1 | NIH | 7/30/2025 | $846,982 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HD117001 | Placental NAD and its effect on labor onset | 000 | 1 | NIH | 7/21/2025 | $164,484 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL173557 | Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure | 000 | 2 | NIH | 2/28/2025 | $678,507 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MH131586 | FastPlex: A Fast Deep Learning Segmentation Method for Accurate Choroid Plexus Morphometry | 000 | 3 | NIH | 3/12/2025 | $500,666 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01MD016068 | Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts | 002 | 4 | NIH | 8/9/2025 | $839,744 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA303219 | Determinants of PARP-inhibitor response in Breast Cancer Patients without germline mutations in BRCA1/2 | 000 | 1 | NIH | 7/15/2025 | $470,567 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AT011043 | Understanding components of mind-body exercise for physical activity engagement in metabolic syndrome | 000 | 5 | NIH | 3/13/2025 | $163,109 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R33AT012284 | Electrophysiological and ultrasound quantitative biomarkers for myofascial pain | 000 | 2 | NIH | 8/13/2025 | $2,313,780 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01LM014689 | HealthCoach: An LLM-driven chatbot to help patients gain actionable insights from their EHR notes and prepare for the next visit | 000 | 1 | NIH | 8/8/2025 | $400,627 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG072899 | Inflammasome activation in modulation of Alzheimer’s Disease by alcohol Administrative Supplement | 000 | 5 | NIH | 3/14/2025 | $192,849 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24AT009465 | Mentoring and Patient-Oriented Research in Integrative Medicine | 001 | 7 | NIH | 3/14/2025 | $140,162 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL177076 | Unraveling The Mechanism of Heart Failure in Hypertrophic Cardiomyopathy with Exercise CMR | 000 | 1 | NIH | 2/24/2025 | $777,258 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG080842 | Role of LRP1 in Alzheimer’s disease | 000 | 3 | NIH | 2/14/2025 | $736,634 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL171855 | Mixed meal tolerance test elicited metabolite responses as novel markers of cardiometabolic risk | 000 | 2 | NIH | 1/28/2025 | $190,670 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00CA259329 | Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis | 001 | 5 | NIH | 5/22/2025 | $24,899 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00CA259329 | Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis | 002 | 5 | NIH | 6/24/2025 | $0 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00CA259329 | Elucidating a Novel Mechanism for LATS1/2 in Suppressing Tumorigenesis | 000 | 5 | NIH | 2/13/2025 | $224,101 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS133187 | Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease | 000 | 2 | NIH | 1/27/2025 | $590,222 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258372 | Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression | 001 | 5 | NIH | 5/22/2025 | $40,032 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258372 | Role of extracellular matrix proteins and tumor stroma in DNA repair and cancer progression | 000 | 5 | NIH | 1/27/2025 | $360,281 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL161259 | Regulation of endothelial cell phosphatidylserine in thrombosis | 000 | 4 | NIH | 11/14/2024 | $165,024 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL174549 | Strategies to Improve the Cardiovascular Health of Rural Working-Age Adults in the United States | 000 | 2 | NIH | 6/5/2025 | $762,175 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK138503 | Integrating signals that control APOL1 gene expression and drive kidney disease | 000 | 12 | NIH | 1/8/2025 | $486,269 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082016 | Wake-sleep Circuitry in Neurodegenerative Dementias | 000 | 2 | NIH | 11/14/2024 | $777,303 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK140473 | Decreased SRD5A2 and Alternative Estrogen Signaling in Prostatic Cell Survival | 000 | 2 | NIH | 7/22/2025 | $507,083 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL175060 | Genetic architecture of tissue factor expression | 000 | 2 | NIH | 8/13/2025 | $656,113 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00AG076739 | Cis proline directed proteotoxicity in the early development and therapy of traumatic brain injury and vascular dementia | 000 | 4 | NIH | 8/6/2025 | $243,917 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 000 | 2 | NIH | 4/23/2025 | $2,211,044 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR021686 | Leveraging SNAP Policies to Improve Cardiovascular Health in the United States | 000 | 2 | NIH | 7/30/2025 | $637,725 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 001 | 5 | NIH | 4/11/2025 | $51,327 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR019628 | Biochemical profiling to identify cardiometabolic responsiveness to an endurance exercise intervention | 000 | 5 | NIH | 12/16/2024 | $461,935 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 001 | 4 | NIH | 6/2/2025 | $58,839 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 000 | 4 | NIH | 1/22/2025 | $529,555 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 001 | 4 | NIH | 6/16/2025 | $38,038 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 4 | NIH | 11/27/2024 | $342,342 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients (PANDORA) - Administrative Supplement | 002 | 5 | NIH | 6/6/2025 | $506,664 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | DP1DK139958 | High-dimensional chemical targeting of multiple neuron types to regulate energy balance | 001 | 2 | NIH | 7/15/2025 | $800,000 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171101 | Rechargeable Anti-thrombogenic Films for Blood Contacting Applications | 000 | 2 | NIH | 12/17/2024 | $652,429 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21HD115117 | Restoration of reduced nitric oxide bioavailability in Preeclampsia | 000 | 2 | NIH | 7/22/2025 | $205,732 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258442 | Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma | 000 | 4 | NIH | 12/12/2024 | $382,146 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK142211 | New Treatment Strategies and Epigenetic Biomarker for Management of BPH | 000 | 2 | NIH | 8/13/2025 | $615,602 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS122589 | Neuronal Circuit Controlling Sleep-Promoting Ventrolateral Preoptic Neurons | 000 | 4 | NIH | 1/6/2025 | $337,669 |
|
